Enovis (ENOV) Debt Ratio (2010 - 2026)
Enovis (ENOV) reported Debt Ratio of 0.35 for Q2 2026, up 21.56% year-over-year from 0.28 in Q2 2025, and up 2.32% on a QoQ basis from 0.34 in Q4 2025.
Enovis (ENOV) has 17 years of Debt Ratio data on file, last reported at 0.35 in Q2 2026.
- Quarterly Debt Ratio rose 21.56% year-over-year to 0.35 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 0.35 (up 21.56% YoY) and the FY2025 annual result came in at 0.34, up 20.03% from the prior year.
- Debt Ratio climbed to 0.35 in Q2 2026 per ENOV's latest filing, from 0.34 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.74 in Q2 2022 and bottomed at 0.06 in Q4 2022.
- The 5-year median for Debt Ratio is 0.24 (2024), against an average of 0.23.
- The widest annual swing landed in 2023, when Debt Ratio sank 91.03%; it then surged 268.59% in 2024.
- Tracing ENOV's Debt Ratio over 5 years: stood at 0.06 in 2022, then soared by 70.38% to 0.1 in 2023, then jumped by 172.54% to 0.28 in 2024, then grew by 20.03% to 0.34 in 2025, then advanced by 2.32% to 0.35 in 2026.
- Per Business Quant, the three latest ENOV Debt Ratio figures stand at 0.35 (Q2 2026), 0.34 (Q4 2025), and 0.31 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn | 0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 0.35 |
| Dec 31, 2025 | 0.34 |
| Oct 3, 2025 | 0.31 |
| Jul 4, 2025 | 0.28 |
| Apr 4, 2025 | 0.28 |
| Dec 31, 2024 | 0.28 |
| Sep 27, 2024 | 0.24 |
| Jun 28, 2024 | 0.25 |
| Mar 29, 2024 | 0.24 |
| Dec 31, 2023 | 0.10 |
| Sep 29, 2023 | 0.09 |
| Jun 30, 2023 | 0.09 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.10 |
| Jul 1, 2022 | 0.10 |
| Apr 1, 2022 | 0.74 |
| Dec 31, 2021 | 0.24 |
| Oct 1, 2021 | 0.20 |
| Jul 2, 2021 | 0.21 |
| Apr 2, 2021 | 0.27 |
| Dec 31, 2020 | 0.30 |
| Oct 2, 2020 | 0.31 |
| Jul 3, 2020 | 0.32 |
| Apr 3, 2020 | 0.34 |
| Dec 31, 2019 | 0.31 |
| Sep 27, 2019 | 0.42 |
| Jun 28, 2019 | 0.42 |
| Mar 29, 2019 | 0.40 |
| Dec 31, 2018 | 0.18 |
| Sep 28, 2018 | 0.18 |
| Jun 29, 2018 | 0.17 |
| Dec 31, 2017 | 0.16 |
| Sep 29, 2017 | 0.20 |
| Jun 30, 2017 | 0.20 |
| Mar 31, 2017 | 0.17 |
| Dec 31, 2016 | 0.20 |
| Sep 30, 2016 | 0.21 |
| Jul 1, 2016 | 0.21 |
| Apr 1, 2016 | 0.22 |
| Dec 31, 2015 | 0.21 |
| Sep 25, 2015 | 0.22 |
| Jun 26, 2015 | 0.20 |
| Mar 27, 2015 | 0.21 |
| Dec 31, 2014 | 0.21 |
| Sep 26, 2014 | 0.22 |
| Jun 27, 2014 | 0.24 |
| Mar 28, 2014 | 0.17 |
| Dec 31, 2013 | 0.23 |
| Sep 27, 2013 | 0.24 |
| Jun 28, 2013 | 0.25 |
| Mar 29, 2013 | 0.26 |
| Dec 31, 2012 | 0.28 |
| Sep 28, 2012 | 0.28 |
| Jun 29, 2012 | 0.28 |
| Mar 30, 2012 | 0.28 |
| Dec 31, 2011 | 0.10 |
| Sep 30, 2011 | 0.07 |
| Jul 1, 2011 | 0.08 |
| Dec 31, 2010 | 0.08 |